General Information of Drug (ID: DMT733X)

Drug Name
LY3041658
Indication
Disease Entry ICD 11 Status REF
Hidradenitis suppurativa ED92.0 Phase 2 [1]
Drug Type
Monoclonal Antibody
Cross-matching ID
TTD ID
DI1TY4

References

1 ClinicalTrials.gov (NCT04493502) A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of LY3041658 in Adults With Moderate-to-Severe Hidradenitis Suppurativa. U.S.National Institutes of Health.